We’re used to seeing biotech stocks surge because of the results of a clinical trial… but it’s quite crazy to see the whole market pinning its hopes on a clinical trial. Gilead’s (GILD) Remdisivir had some weak results leak last week and that helped inspire the market selloff (“Oh no, we won’t get a drug […]
Articles
- Most Relevant
- Most Recent
Lots of folks are asking about this one, so we’re pulling it to the top of the page again — the article below has not been updated or revised since it ran on March 10, though in the interim the stock teased bumped from $10 to $13 and is now back down below $12, with […]
I’ve had quite a few readers write in to ask me about silver lately — there was a spurt of “silver will be better than gold” newsletter teasers over the Summer, and this latest pitch from the Insiders Strategy Group folks for their Macro Trader newsletter has been filling up the inbox … … so […]
Earlier this week, when I was looking into Teeka Tiwari’s pitch about stealing from Vladimir Putin, I promised that I’d follow up and look at the gold investment he was also teasing in that letter… so let’s get to it! His overall spiel is selling something he calls the “New Cold War Playbook” as a […]
This article was originally published on January 6, 2020. Neither the ad we’re covering nor this article has been updated since then, though I’ve added a small update note at the end. The stock is back to where it was before the first promo pitch was mailed, and the latest emails pointing to this teaser […]
I guess this is shaping up to be another “marijuana week” here at Stock Gumshoe… this latest pitch talks up a chance at making five times your money on “a marijuana stock opportunity that almost NO ONE is talking about yet.” Which, of course, is music to our ears — we do love a good […]
Regular investors are getting interested in gold again, after the big run it had in the first half of this year… and many of us also remember the ludicrous returns that many folks got from buying bitcoin early on… so it’s only natural that this ad puts our greed receptors into overdrive: “The time to […]
Yesterday we looked at Louis Navellier’s pitch about his “bulletproof” stocks to buy — mostly pretty reasonable growth stocks that are priced like growth stocks, but not the crazy hyper-momentum valuations that scare people. Today I thought we’d take a quick moment to ID a couple of the other ideas in his ad. The big […]
I do have a quick teaser unveiling to share with you for today’s Friday File, but I want to start with a look at a stock that I own and that I suggested to the Irregulars several years ago, Sprott Resource Corp. (SCP in Canada, SCPZF on the pink sheets) Why? Because they just agreed […]
I’ve had dozens of readers send this one along, most with a long line of question marks. The teaser has been around for a while (a couple years, as far as I can tell), but it continues to spark interest — especially with the dollar at ridiculous lows, inflation fears bubbling, and gold near $1,000 […]
I don’t necessarily like to gang up on the same publisher two days in a row — but, well, the great legions of Gumshoe readers are asking for it, and we do aim to please. So just like yesterday, today we’re digging through some Motley Fool foofaraw, an ad they’ve been sending out this week […]
This ad about a “Donald Trump investment” is sending a lot of questions our way, so we’re going to take a look at it for you in today’s Friday File… and I’ve also got an update on Sandstorm Gold to share, plus a quick look at the idea of “protection” from market declines and how […]
These kinds of secret income pitches get sent around all the time, and that’s been true ever since Stock Gumshoe started publishing in 2007 — some of our very first articles were about deciphering the “secrets” behind schemes described as “801k Plans” (because they’re “twice as good as 401k plans“) and other terms that are […]
No, you’re not getting any free money. OK, maybe that’s not fair — but I like to put that disclaimer up front, for those who haven’t been around Stock Gumshoe very long and might mistakenly believe that the marketing craziness put out by the investment newsletters is somehow a fair reflection of reality. Christian Dehaemer […]
What’s the world’s most powerful company, second in size as an “economic entity” only to the United States and China? Good question, right? That’s why this ad from Nicholas Vardy caught my eye — he’s selling us on the potential for 127% returns if we invest in this company (assuming we subscribe to his Alpha […]
We’ve gotten a lot of questions about the latest spiel from Marin Katusa, so I’m going to take a few minutes to dig into that today. I’ll warn you up front that I probably can’t be definitive about answers, because it looks like the ad doesn’t go into much detail on this “best lithium stock […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can find his bio and his past articles on his Stock Gumshoe page.] “The universe (which others call the Library) is composed of an indefinite and […]
This article was originally published on January 11, but the Casey folks are promoting these same five stocks quite similarly with the bait of their “Become a Marijuana Millionaire in 2018” report, focusing on the impending Canadian legalization this summer, so we’re re-posting our January article here to answer some reader questions. The five stocks […]
So… the Fed failed to do anything, which I guess means that the wild predictions about the end of western civilization hitting us on September 18th are going to get pushed off again. Maybe we’ll soon start to see ads about how the next Greater Depression will start on October 28, or December 16…. or, […]
First, let’s get the week’s changes to my Real Money Portfolio out of the way… and after that, I’ve got a few other updates on stocks that I follow for you, dear Irregulars. We’ve got a new stock in the portfolio…. As of tomorrow, I will have a position in NVIDIA (NVDA). This is a […]
The Apple of weed – This Tiny Little Pot Company Already Has the Most Profitable Retail Store in America…Anyone know what penny stock Ray Blanco talks about?
I haven’t yet gotten to a few of my largest holdings in our Annual Review, so that’s where I’ll begin today — with the insurance conglomerates Berkshire Hathaway (BRK-B), Markel (MKL), and Fairfax Financial (FFH.TO, FRFHF), as well as the somewhat related names Fairfax India (FIH-U.TO, FFXDF) and Boston Omaha (BOMN). I should be clear […]
Chances are not many of us observed New Year’s Eve with celebratory toasts to the glorious year gone by. Rather, we bid goodbye to 2018 and hoped 2019 would be a better year – for ourselves, our near and dear, our country, and our planet. However, as I wade through the volumes of healthcare-related stuff […]
I’ll grant that my headline is meant to be catchy and induce you to read this epistle. Some of you will ask what is ketamine anyway, and most of you will know from the get-go that ketamine, whatever the heck it is, will turn out to be neither a menace nor a miracle, but something […]
Time, once again, for the Annual Review of all of the stocks I hold in the Real Money Portfolio. Many of my positions are built up over many years, and sometimes they’re stocks that don’t generate a lot of news or attention for months at a time, so I promise each January to cover every […]
This hit my in basket today pitching a new type of cathode hitting the market soon that will be more efficient than the current designs. Pitched as a nightmare for Tesla, Ford and others. Mercedes is in the lead for introducing vehicles with this technology 1-1-8 refers to the ratio of cobalt manganese and nickel […]
The response was pretty overwhelmingly positive when I started sending out those “Trade Note” emails this week… so I’ll stick with it for a while, at least, and see how this goes. What does that mean? Same day buy/sell notes about my Real Money Portfolio will be sent to the Irregulars going forward, in hopes […]
Thanks so much to the new folks who’ve joined us as Irregulars this week — we’re midway through our annual charitable membership drive, and it’s looking pretty good… I’m hoping we can get our totals up to last year’s numbers, and we’re almost halfway there with a donation pile of close to $6,000 now. That’s […]
A fantastic market last week, a terrible market this week… it’s time, once again for another episode of “Turn Off CNBC and Have Some Perspective!” I won’t go into a long screed about long-term investing here, but I thought I’d just share one of my favorite charts — I see someone post something like this […]
That’s a good headline, right? I pulled that quote from a Tony Daltorio ad that I saw over the weekend — and it seems to have the finger on the pulse of my nerves, at least, because combining those phrases “blue chip” and “windfall” in one sentence really give me a nice, warm feeling in […]
Happy holiday season, campers! What’s up with the Real Money Portfolio as we head into a slow Thanksgiving week? The most brutal takedown of the week was NVIDIA (NVDA), which I’m sure many of you noticed this morning — that’s a stock that hit a stop loss a while back for us (I was watching […]
While we wait to see what Berkshire Hathaway’s quarter looked like, how’s the rest of the portfolio holding up? Holy Cow, Starbucks (SBUX)! Haven’t seen that stock take this big of a pop after earnings in a long time, and sentiment seems to have changed so quickly to a “this is a safe capital return […]
This ad sounds very similar to some that we’ve looked at in the past, but readers always want to hear about these “top stock for the year” pitches so I thought I’d give it a look… after all, who doesn’t want an “almost easy double?” Mike Cintolo is using this spiel to sell his Cabot […]
The Money Map folks have decided that it’s time to go “all in” on cannabis, and for them that means starting a new investment research business that they call the National Institute for Cannabis Investors, and selling memberships in that group by teasing their favorite “special reports” on some appealing marijuana stocks that they’ll give […]
The next wireless standard to be adopted by telecom service providers might be the biggest one since 3G enabled the first real “high speed” data and reasonably useful internet access by smart phones. And new wireless standards are always of interest to investors, not least because the growth of smartphones has tracked the improving networks […]
If you’re wondering whether it’s interest rates or just “worry about overvaluation or growth” that’s making the stock market go crazy this week, or whether it’s the trade war or political upheaval or something else, well, join the club. There’s some indication that traders are in fear of the “slowdown” that could be caused by […]
I guess now pretty much everyone has jumped aboard the Marijuana bandwagon — the Motley Fool is a bit later to the party, having just announced its Marijuana Masters investing service ($1,499, no refunds), helmed by David Kretzmann (a new name to me), so let’s see what it is that the typically much more mainstream […]
I feel like I’m waggling back and forth on a strange tightrope, as I’ve been doing for about a year and a half now, and I sum it up kinda like this: I’m quite nervous about the valuations of the overall market and about the massive debt load for both governments and individuals in the […]
Ray Blanco seems to love pitching a good “results coming soon” story for his FDA Trader ($1,495, no refunds) newsletter over at Agora, and this one is no different from dozens of others he has touted in the past… though the stock is one I haven’t seen him tease before. OK, fine, yes, I know […]
Have you been watching what’s going on with the trendy pot stocks lately? Holy crap. This reminds me now of 1999 more than it reminds me of the cryptocurrency bubble of this past winter — these larger marijuana companies, like many of the dot com companies (and unlike most cryptos, of course), are real businesses […]